Category Archives: Stem Cell Research
Stem Cell Study Shows Promising Results Against Heart Failure
THURSDAY, May 10 (HealthDay News) — A new treatment that involves spinning bone marrow stem cells to enhance their healing potential may help people with advanced heart failure feel and function better, a small study suggests. Continue reading
StemCells, Inc. Reports First Quarter 2012 Financial Results and Provides Business Update
NEWARK, Calif., May 10, 2012 (GLOBE NEWSWIRE) — StemCells, Inc. (Nasdaq:STEM – News), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem cell-based research and drug discovery, today reported financial results for the first quarter ended March 31, 2012 and provided a business update Continue reading
International Stem Cell Corporation Announces New Stem Cell Manufacturing Technologies to Support its Therapeutic …
CARLSBAD, Calif.–(BUSINESS WIRE)– International Stem Cell Corporation (OTCBB: ISCO.OB – News) www.internationalstemcell.com today announced that the Company has developed new technologies to commercialize the use of human parthenogenetic stem cells (hpSC) to treat human diseases. The methods announced today are capable of producing populations of stem cells and their therapeutically valuable derivatives not only to a higher level of purity but also at a cost that is approximately several times lower than previously reported techniques. Continue reading
StemCells, Inc. Announces Webcast to Discuss First Quarter 2012 Financial Results and Business Update
NEWARK, Calif., May 7, 2012 (GLOBE NEWSWIRE) — StemCells, Inc. (Nasdaq:STEM – News), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem cell-based research and drug discovery, announced today that it will release financial results for the first quarter ended March 31, 2012 after the market close on Thursday, May 10. In connection with this announcement, StemCells will host a conference call and webcast to discuss its results and an update on its business at 1:30 p.m Continue reading
Hamilton Thorne Receives CE Mark for Its LYKOS(R) Clinical Laser System
BEVERLY, MA and TORONTO–(Marketwire -05/08/12)- Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced that the Company has received a CE Mark for its new LYKOS assisted clinical reproductive laser system. The CE Mark provides conformity to European Medical Device Directive 93/42/EEC, which allows a company to market and sell products in the European Economic Area (EEA) Continue reading
Fluidigm and the Broad Institute Establish Single-Cell Genomics Research Center
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)– The Broad Institute and Fluidigm Corporation (NASDAQ:FLDM – News) today announced the launch of a new research center dedicated to accelerating the development of research methods and discoveries in mammalian single-cell genomics. Continue reading
NY medical schools chart progress with stem cells
ALBANY, N.Y. (AP) — Almost halfway through a $600 million state program supporting stem cell research, eight medical schools around New York are reporting progress on projects such as replicating liver cells and eradicating leukemia cells. A new report from Associated Medical Schools of New York updates work at the institutions where hundreds of researchers are starting to unravel causes and potential treatments for conditions ranging from autism to heart disease and cancer. Continue reading
Navigating the IP Minefield of Human Embryonic Stem Cell Development
FARMINGTON, Conn., May 8, 2012 /PRNewswire-iReach/ — Global Information Inc. is pleased to announce two significant new reports Opportunities in Human Embryonic Stem Cell (hESC) ProductsHuman embryonic stem cells (hESCs) are stem cells derived from the inner cell mass of a blastocyst, the stage reached 4 to 5 days after fertilization. Continue reading
2 Cell Transplantation studies impact dental stem cell research for therapeutic purposes
Public release date: 8-May-2012 [ | E-mail | Share ] Contact: David Eve celltransplantation@gmail.com Cell Transplantation Center of Excellence for Aging and Brain Repair Tampa, Fla. (May. 8, 2012) Two studies appearing in a recent issue of Cell Transplantation (20:11-12), now freely available on-line at http://www.ingentaconnect.com/content/cog/ct/, evaluate stem cells derived from dental tissues for characteristics that may make them therapeutically useful and appropriate for transplantation purposes Continue reading